Dr. Severson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
Dept of Neurology
Boston, MA 02115Phone+1 617-732-7432Fax+1 857-307-0899
Education & Training
Yale-New Haven Medical CenterInternship, Internal Medicine, 2003 - 2004
Yale School of MedicineClass of 2003
Certifications & Licensure
MA State Medical License 2009 - 2024- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis Start of enrollment: 2013 Nov 01
- Effect of MD1003 in Progressive Multiple Sclerosis (SPI2) Start of enrollment: 2016 Dec 01
Publications & Presentations
PubMed
- 116 citationsSoluble IL-2RA levels in multiple sclerosis subjects and the effect of soluble IL-2RA on immune responses.Lisa M. Maier, David E. Anderson, Christopher Severson, Clare Baecher-Allan, Brian C. Healy
Journal of Immunology. 2009-02-01 - 14 citationsHumoral response to COVID-19 vaccination in MS patients on disease modifying therapy: Immune profiles and clinical outcomes.Kathryn B Holroyd, Brian C Healy, Sarah Conway, Maria Houtchens, Rohit Bakshi
Multiple Sclerosis and Related Disorders. 2022-11-01 - 172 citationsPhase 2 trial of ibudilast in progressive multiple sclerosisRobert J. Fox, Christopher S. Coffey, Robin Conwit, Merit Cudkowicz, Trevis Gleason
The New England Journal of Medicine. 2018-08-30
Press Mentions
Christopher Severson, MD, a Neurologist with Brigham and Women’s HospitalAugust 26th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
